Live Breaking News & Updates on Replimune group

Stay informed with the latest breaking news from Replimune group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Replimune group and stay connected to the pulse of your community

Replimune Group (NASDAQ:REPL) & Zura Bio (NASDAQ:ZURA) Critical Comparison

Replimune Group (NASDAQ:REPL) & Zura Bio (NASDAQ:ZURA) Critical Comparison
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nevada , United-states , Massachusetts , Zura-bio , Replimune-group , Replimune-group-inc , News-ratings-for-replimune-group-daily , Get-free-report , Given-zura-bio , Bio-limited , Replimune-group-daily ,

Replimune Group (NASDAQ:REPL) and Zura Bio (NASDAQ:ZURA) Head-To-Head Comparison

Zura Bio (NASDAQ:ZURA – Get Free Report) and Replimune Group (NASDAQ:REPL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Insider & Institutional Ownership 61.1% of Zura […]

Nevada , United-states , Massachusetts , Zura-bio , Replimune-group-inc , Replimune-group , Get-free-report , Given-zura-bio , Bio-limited , Zura-bio-daily , Nasdaq-zura , Zura

Head-To-Head Survey: Replimune Group (NASDAQ:REPL) & Zura Bio (NASDAQ:ZURA)

Replimune Group (NASDAQ:REPL – Get Free Report) and Zura Bio (NASDAQ:ZURA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Risk & Volatility Replimune Group has a […]

Nevada , United-states , Massachusetts , Zura-bio , Replimune-group , News-ratings-for-replimune-group-daily , Replimune-group-inc , Get-free-report , Given-zura-bio , Bio-limited , Replimune-group-daily , Nasdaq-repl

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ukraine , Israel , Russia , Ukrainian , Russian , Inquiriesarleen-goldenbergreplimune , Inquirieschris-brinzeyicr-westwicke , Carolyn-trott , Replimune-group-inc , Nasdaq , Securities-exchange , Exchange-commission

Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO

(RTTNews) - Biotechnology company Replimune Group, Inc. (REPL) announced Tuesday changes to its executive leadership team designed to support the ...

Sushil-patel , Philip-astley-sparke , Replimune-group-inc , Genentech , Replimune-group , Executive-chairman , Chief-commercial-officer , Chief-strategy ,

Replimune Group (NASDAQ:REPL) Trading Up 5.3%

Replimune Group (NASDAQ:REPL) Trading Up 5.3%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Barclays , News-ratings-for-replimune-group-daily , Goldman-sachs-group-inc , Fcpm-iii-services , Replimune-group-inc , Replimune-group-company-profile , Replimune-group-price-performance , Replimune-group , Institutional-investors-weigh-in-on-replimune-group , Pricet-rowe-associates-inc , Nasdaq

Profund Advisors LLC Grows Stock Position in Replimune Group, Inc. (NASDAQ:REPL)

Profund Advisors LLC lifted its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 19.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,557 shares of the company’s stock after purchasing an additional 5,045 shares during the quarter. Profund Advisors […]

Replimune-group-price-performance , Nasdaq , Blackrock-inc , Replimune-group , News-ratings-for-replimune-group-daily , Vanguard-group-inc , Securities-exchange-commission , Replimune-group-company-profile , Profund-advisors , Quarter-for-replimune-group , Barclays

12 Best Medical Stocks to Buy Under $10

In this article, we will take a look at the 12 best medical stocks to buy under $10. To skip our analysis of the latest trends, and market activity, you can go directly to see the 5 Best Medical Stocks to Buy Under $10. The healthcare sector spans medical stocks including biotechnology companies, health insurance […]

Amsterdam , Noord-holland , Netherlands , Menlo-park , California , United-states , Florida , Pacific-biosciences , Andreas-argyrides , Robert-burns , John-sourbeer , Ryan-wilder-vestal

12 Best Medical Stocks to Buy Under $10 - Insider Monkey

In this article, we will take a look at the 12 best medical stocks to buy under $10.

Menlo-park , California , United-states , Amsterdam , Noord-holland , Netherlands , Florida , Pacific-biosciences , Andreas-argyrides , Ryan-wilder-vestal , Eli-lilly , Robert-burns

Loomis Sayles & Co. L P Raises Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)

Loomis Sayles & Co. L P grew its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 8.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,290,450 shares of the company’s stock after purchasing an additional 103,223 shares during the quarter. Loomis Sayles & Co. L P’s holdings in Replimune Group […]

Loomis-sayles-co , Replimune-group , Replimune-group-inc , Charles-schwab-investment-management-inc , News-ratings-for-replimune-group-daily , Quarter-for-replimune-group , Barclays-plc , Replimune-group-price-performance , Barclays , Nasdaq , Citigroup-inc